The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We’ve Come, How Much Further We Need to Go.
J Bone Miner Res. 2018 Mar;33(3):371-385. doi: 10.1002/jbmr.3400. Epub 2018 Feb 22. PubMed PMID: 29405383. Manolagas SC.
Mediterranean diet, diet quality, and bone mineral content in adolescents: the HELENA study.
Osteoporos Int. 2018 Mar 5. doi: 10.1007/s00198-018-4427-7 Julián C, Huybrechts I, Gracia-Marco L, González-Gil EM, Gutiérrez Á, González-Gross M, Marcos A, Widhalm K, Kafatos A, Vicente-Rodríguez G, Moreno LA.
Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment.
Sci Rep. 2018 Mar 28;8(1):5318. doi: 10.1038/s41598-018-23532-x. Elango J, Sanchez C, de Val JEMS, Henrotin Y, Wang S, Motaung KSCM, Guo R, Wang C, Robinson J, Regenstein JM, Bao B, Wu W.
Osseointegration mechanisms: a proteomic approach.
J Biol Inorg Chem. 2018 May;23(3):459-470. doi: 10.1007/s00775-018-1553-9. Araújo-Gomes N, Romero-Gavilán F, García-Arnáez I, Martínez-Ramos C, Sánchez-Pérez AM, Azkargorta M, Elortza F, de Llano JJM, Gurruchaga M, Goñi I, Suay J. https://www.ncbi.nlm.nih.gov/pubmed/29572572
Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on “Variability of denosumab densitometric response in postmenopausal osteoporosis.
Rheumatol Int. 2018 Jun;38(6):1161-1162. doi: 10.1007/s00296-018-4007-3. Torrente-Segarra V, Roig-Vilaseca D.
Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2018 Feb;29(2):265-286. doi: 10.1007/s00198-017-4339-y. Epub 2018 Jan 6. Varahra A, Rodrigues IB, MacDermid JC, Bryant D, Birmingham T.
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
Osteoporos Int. 2018 Feb;29(2):501-506. doi: 10.1007/s00198-017-4286-7. Epub 2017 Oct 30. Greenspan SL, Vujevich K, Britton C, Herradura A, Gruen G, Tarkin I, Siska P, Hamlin B, Perera S.
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study.
J Bone Miner Res. 2018 Feb;33(2):298-306. Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Melby TE, Ruff … Leer más
TNFα blockade mediates bone protection in antigen-induced arthritis by reducing osteoclast precursor supply.
Bone. 2018 Feb; 107:56-65 Uster S, Matos Coelho F, Aeberli D, Stein JV, Hofstetter W, Engelhardt R, Seitz M.
Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Calcif Tissue Int 2018 2018 Feb;102(2):227-250. doi: 10.1007/s00223-017-0353-5. Epub 2017 Oct 27. Sousa S, Clézardin P
